2023-07-03 06:38:20 ET
- Bionomics ( NASDAQ: BNOX ) has appointed Tim Cunningham of Danforth Associates as Chief Financial Officer, effective 1 July 2023.
- Cunningham has most recently served as a Chief Financial Officer Consultant at Danforth, since September 2020.
- The company also appoints Alan Fisher, currently a non-executive member of the board and Chair of the Audit & Risk Committee as Non-Executive Chair of the board, effective from 1 July 2023.
- Fisher succeeds Errol De Souza, who remains on the board as a Non-Executive Director.
- Concurrently, the firm announced the appointment of Julie Kerner, as Senior Vice President of Business Operations, and Atul R. Mahableshwarkar, as the Acting Chief Medical Officer and engaged Francisco Bejar as a strategic advisor to head the business development efforts in the U.S. and abroad, whilst Connor Bernstein, Vice President, Strategy and Development, steps down from his role with effect from 30 June 2023.
For further details see:
Bionomics names Alan Fisher as chair, Tim Cunningham as CFO